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ABSTRACT
Fairly large number of mumps virus infections present atypically without parotitis leading to delay 
in diagnosis and increased morbidity. Awareness of such presentations and inclusion of serological 
test for detecting IgM-specifi c antibodies could help in solving diagnostic dilemma, especially in 
unvaccinated individuals from developing countries.
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INTRODUCTION
Mumps is an acute viral illness characterized by 
unilateral or bilateral painful swelling of the parot-
id or other salivary glands. In unvaccinated popu-
lations, an estimated 30-70% of mumps infec-
tions are associated with typical acute parotitis.1,2 
However, as many as 20% of infections are asymp-
tomatic and nearly 50% are associated with non-
specifi c or primarily respiratory symptoms, with 
or without parotitis.1 Atypical mumps infection 
presentations include meningitis, epididymitis, 
orchitis, nephritis, pancreatitis, myocarditis, and 
others3,4 and in these cases laboratory confi rma-
tion is required. Mumps specifi c-laboratory assays 
include virus isolation from saliva or urine, anti-
mumps IgM antibody detection in blood, four-
fold rising in titers of anti-mumps IgG/neutral-
izing antibodies in blood and/or demonstration 
of viral RNA in cerebral spinal ﬂ uid (CSF).4,5 A 
rapid and reliable laboratory diagnosis of mumps 
virus infection is essential especially in cases with 
atypical presentations.6 Here we present a series 
of eight patients with atypical mumps infection 
in which anti-mumps IgM was detected by indi-
rect immunoﬂ uorescence assay (IFA), proving to 
be very useful in disease confi rmation and early 
settling diagnostic dilemma.
PATIENTS AND METHODS
Eight patients with laboratory confi rmed mumps 
infection attended at Kasturba Hospital, a tertiary 
care teaching hospital in Manipal, South India, 
during the year of 2005 were evaluated according 
to clinical and laboratorial data. All patients, in-
cluding those with parotitis, underwent empirical 
therapy before serological and virology analysis. 
Brieﬂ y, blood and CSF samples were evaluated 
for the presence of anti-mumps IgM antibody by 
IFA (prepared and standardized in house). These 
specimens were also tested for specifi c IgM anti-
bodies against herpes simplex viruses (HSV) and 
Japanese encephalitis virus (JEV). Polymerase 
chain reaction was carried out on CSF samples to 
rule out HSV-1 and HSV-2 infection. Saliva and 
urine samples were processed for mumps virus 
isolation on Vero cells line.
RESULTS 
The characteristics of patients, clinical pres-
entation at admission, and outcome diseases, 
as well as laboratorial data is presented in 
Table 1. Four cases (50%) were children between 
5-13 years (three males and one female) and 
four adults (50%) (two males and two females, 
mean age of 17 years). Mumps was not the pri-
mary diagnosis at admission in six out of eight 
cases, as clinically evident parotitis was seen 
only in two cases. Even in these two cases, the 
admission was for meningitis or epididymo- 
orchitis. Five patients including three children 
and two adults had meningitis or meningoen-
cephalitis at the time of admission. One child 
had developed nephritis and renal failure, 
while one adult was presented with acute res-
piratory distress syndrome (ARDS). All eight 
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patients tested positive for anti-mumps IgM in blood and/
or CSF. However, mumps virus isolation in saliva was suc-
cessful only in two cases, one from the ARDS and the other 
from epididymoorchitis with parotitis. Six patients recov-
ered completely, except one adult patient with meningitis, 
who developed sensorineural hearing defi cit, while the child 
with nephritis later died due to renal failure.
DISCUSSION
The use of effective vaccine in developed countries successfully 
reduced mumps virus infection, though outbreaks are often 
reported.7 Due to absence of effective vaccination programs, 
mumps is still a major health problem in several developing 
countries. Mumps disease burden in India is still not completely 
understood. Few published reports indicate more occurrence of 
the disease in children of the age group 5-9 years.8,9 The clinical 
presentation of mumps is not necessarily typical. Clinical men-
ingitis occurs in 1-10% of patients with mumps parotitis, but 
only 40-50% of patients with mumps meningitis, confi rmed 
by serology or virus isolation, have parotitis.10 Large number 
of atypical presentations of mumps highlights the weakness of 
clinical diagnosis and the need of reliable rapid diagnostic tests. 
Virus isolation from saliva or urine is time consuming and la-
bor intensive. RT-PCR for viral RNA detection is considered to 
be useful in diagnosing central nervous system (CNS) involve-
ment by mumps virus, however, this technique is not available 
in most laboratories of developing countries. In unvaccinated 
subjects, mumps specifi c IgM is almost always detectable in se-
rum as early as 11 days after exposure, and by the time of clini-
cal illness. Cases of atypical and complicated mumps are often 
misdiagnosed or face delayed diagnosis, while extensive search 
for other etiologies are being conducted. This delays the insti-
tution of appropriate supportive therapy leading to increased 
morbidity and mortality as observed also in the present study. 
Moreover, early diagnosis could help to reduce virus spread-
ing by patient isolation. High degree of clinical suspicion 
and inclusion of simple and rapid tests, such as serology, for 
detecting mumps IgM antibodies during early investigative 
procedures could reduce diagnostic dilemma. IFA for detect-
ing IgM antibodies is a very rapid and reliable method, which 
can be performed even by laboratories where virus isolation is 
unavailable. Together, these observations could help clinicians 
to suspect mumps viruses as another etiological agent, mainly 
in the CNS diseases, especially in countries where the virus is 
endemic and the vaccine coverage is still poor.
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Role of laboratory in rapid diagnosis of mumps
Table 1. Clinical and laboratorial data from mumps-infected patients with atypical disease presentations
Pt Age/gender Clinical features Vaccination      Mumps IgM Virus Pleocytosis  Other tests Outcome
No   status    antibody isolation    
           blood  CSF saliva CSF HSV-PCR
         JEV serology 
1 7 yrs/female  Meningitis _ +  + _ Yes _ Recovered
2 5 yrs/male  Meningitis  _ +  + _ Yes _ Recovered
3 7 yrs/male  Meningitis, Parotitis _ +  + _ Yes _ Recovered
4 32 yrs/female Meningitis  _ +  + _ Yes _ Recovered
5 23 yrs/female Meningitis  _ +  + _ Yes _ Sensorineural 
          hearing deficit
6 13 yrs/male Nephritis _ +  NA _ NA NA Died
7 28 yrs/male ARDS, Orchitis _ +  NA + NA NA Recovered
8 26 yrs/male Parotitis, Orchitis _ +  NA + NA NA Recovered
NA: not applicable.
